Effect of Preoperative Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Hemodynamic Variables in Pediatric Patients Undergoing Cardiopulmonary Bypass

Chinwe C. Ajuba-Iwuji, Sahitya Puttreddy, Bryan G. Maxwell, Melania Bembea, Luca Vricella, Eugenie Heitmiller

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Some have suggested that children undergoing cardiac surgery who receive angiotensin-converting enzyme (ACE) inhibitors experience a greater degree of hypotension after anesthesia induction and in the immediate postcardiopulmonary bypass period than children who did not receive these drugs. Therefore, we examined the effect of ACE inhibitor/angiotensin II receptor blocker (ARB) therapy on intraoperative hemodynamics and vasopressor use in pediatric patients undergoing cardiac surgery. In a retrospective cohort study of patients younger than 18 years who underwent cardiopulmonary bypass between March 1, 2010, and April 1, 2011, we compared intraoperative hemodynamics and vasopressor use between patients who received preoperative ACE inhibitor/ARB therapy and those who did not. The primary outcome was vasoactive infusion score after cardiopulmonary bypass. The occurrence of hypotension did not differ significantly between the ACE inhibitor/ARB group and the control group during induction of anesthesia or at any time point after cardiopulmonary bypass. At 0, 30, 60, and 90 minutes after cessation of cardiopulmonary bypass, patients on ACE inhibitor/ARB therapy tended to have a higher vasoactive infusion score (7.1, 7.6, 9.4, and 11.3) than patients in the control group (6.3, 6.1, 6.0, and 6.7). Although this difference became more pronounced over time, it did not reach statistical significance. The use of preoperative ACE inhibitors and ARBs in pediatric patients undergoing cardiac surgery did not significantly increase the incidence of hypotension after induction of anesthesia and did not increase significantly the vasoconstrictor requirements upon weaning from cardiopulmonary bypass; however, additional prospective studies are needed.

Original languageEnglish
Pages (from-to)515-521
Number of pages7
JournalWorld Journal for Pediatric and Congenital Heart Surgery
Volume5
Issue number4
DOIs
Publication statusPublished - 01-01-2014
Externally publishedYes

Fingerprint

Angiotensin Receptor Antagonists
Cardiopulmonary Bypass
Angiotensin-Converting Enzyme Inhibitors
Hemodynamics
Pediatrics
Hypotension
Thoracic Surgery
Anesthesia
Control Groups
Vasoconstrictor Agents
Cohort Studies
Therapeutics
Retrospective Studies
Prospective Studies
Incidence
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Ajuba-Iwuji, Chinwe C. ; Puttreddy, Sahitya ; Maxwell, Bryan G. ; Bembea, Melania ; Vricella, Luca ; Heitmiller, Eugenie. / Effect of Preoperative Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Hemodynamic Variables in Pediatric Patients Undergoing Cardiopulmonary Bypass. In: World Journal for Pediatric and Congenital Heart Surgery. 2014 ; Vol. 5, No. 4. pp. 515-521.
@article{639b587efb4b47bab3190421fc1eb0b2,
title = "Effect of Preoperative Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Hemodynamic Variables in Pediatric Patients Undergoing Cardiopulmonary Bypass",
abstract = "Some have suggested that children undergoing cardiac surgery who receive angiotensin-converting enzyme (ACE) inhibitors experience a greater degree of hypotension after anesthesia induction and in the immediate postcardiopulmonary bypass period than children who did not receive these drugs. Therefore, we examined the effect of ACE inhibitor/angiotensin II receptor blocker (ARB) therapy on intraoperative hemodynamics and vasopressor use in pediatric patients undergoing cardiac surgery. In a retrospective cohort study of patients younger than 18 years who underwent cardiopulmonary bypass between March 1, 2010, and April 1, 2011, we compared intraoperative hemodynamics and vasopressor use between patients who received preoperative ACE inhibitor/ARB therapy and those who did not. The primary outcome was vasoactive infusion score after cardiopulmonary bypass. The occurrence of hypotension did not differ significantly between the ACE inhibitor/ARB group and the control group during induction of anesthesia or at any time point after cardiopulmonary bypass. At 0, 30, 60, and 90 minutes after cessation of cardiopulmonary bypass, patients on ACE inhibitor/ARB therapy tended to have a higher vasoactive infusion score (7.1, 7.6, 9.4, and 11.3) than patients in the control group (6.3, 6.1, 6.0, and 6.7). Although this difference became more pronounced over time, it did not reach statistical significance. The use of preoperative ACE inhibitors and ARBs in pediatric patients undergoing cardiac surgery did not significantly increase the incidence of hypotension after induction of anesthesia and did not increase significantly the vasoconstrictor requirements upon weaning from cardiopulmonary bypass; however, additional prospective studies are needed.",
author = "Ajuba-Iwuji, {Chinwe C.} and Sahitya Puttreddy and Maxwell, {Bryan G.} and Melania Bembea and Luca Vricella and Eugenie Heitmiller",
year = "2014",
month = "1",
day = "1",
doi = "10.1177/2150135114549748",
language = "English",
volume = "5",
pages = "515--521",
journal = "World journal for pediatric & congenital heart surgery",
issn = "2150-1351",
publisher = "Sage Periodicals Press",
number = "4",

}

Effect of Preoperative Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Hemodynamic Variables in Pediatric Patients Undergoing Cardiopulmonary Bypass. / Ajuba-Iwuji, Chinwe C.; Puttreddy, Sahitya; Maxwell, Bryan G.; Bembea, Melania; Vricella, Luca; Heitmiller, Eugenie.

In: World Journal for Pediatric and Congenital Heart Surgery, Vol. 5, No. 4, 01.01.2014, p. 515-521.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of Preoperative Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Hemodynamic Variables in Pediatric Patients Undergoing Cardiopulmonary Bypass

AU - Ajuba-Iwuji, Chinwe C.

AU - Puttreddy, Sahitya

AU - Maxwell, Bryan G.

AU - Bembea, Melania

AU - Vricella, Luca

AU - Heitmiller, Eugenie

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Some have suggested that children undergoing cardiac surgery who receive angiotensin-converting enzyme (ACE) inhibitors experience a greater degree of hypotension after anesthesia induction and in the immediate postcardiopulmonary bypass period than children who did not receive these drugs. Therefore, we examined the effect of ACE inhibitor/angiotensin II receptor blocker (ARB) therapy on intraoperative hemodynamics and vasopressor use in pediatric patients undergoing cardiac surgery. In a retrospective cohort study of patients younger than 18 years who underwent cardiopulmonary bypass between March 1, 2010, and April 1, 2011, we compared intraoperative hemodynamics and vasopressor use between patients who received preoperative ACE inhibitor/ARB therapy and those who did not. The primary outcome was vasoactive infusion score after cardiopulmonary bypass. The occurrence of hypotension did not differ significantly between the ACE inhibitor/ARB group and the control group during induction of anesthesia or at any time point after cardiopulmonary bypass. At 0, 30, 60, and 90 minutes after cessation of cardiopulmonary bypass, patients on ACE inhibitor/ARB therapy tended to have a higher vasoactive infusion score (7.1, 7.6, 9.4, and 11.3) than patients in the control group (6.3, 6.1, 6.0, and 6.7). Although this difference became more pronounced over time, it did not reach statistical significance. The use of preoperative ACE inhibitors and ARBs in pediatric patients undergoing cardiac surgery did not significantly increase the incidence of hypotension after induction of anesthesia and did not increase significantly the vasoconstrictor requirements upon weaning from cardiopulmonary bypass; however, additional prospective studies are needed.

AB - Some have suggested that children undergoing cardiac surgery who receive angiotensin-converting enzyme (ACE) inhibitors experience a greater degree of hypotension after anesthesia induction and in the immediate postcardiopulmonary bypass period than children who did not receive these drugs. Therefore, we examined the effect of ACE inhibitor/angiotensin II receptor blocker (ARB) therapy on intraoperative hemodynamics and vasopressor use in pediatric patients undergoing cardiac surgery. In a retrospective cohort study of patients younger than 18 years who underwent cardiopulmonary bypass between March 1, 2010, and April 1, 2011, we compared intraoperative hemodynamics and vasopressor use between patients who received preoperative ACE inhibitor/ARB therapy and those who did not. The primary outcome was vasoactive infusion score after cardiopulmonary bypass. The occurrence of hypotension did not differ significantly between the ACE inhibitor/ARB group and the control group during induction of anesthesia or at any time point after cardiopulmonary bypass. At 0, 30, 60, and 90 minutes after cessation of cardiopulmonary bypass, patients on ACE inhibitor/ARB therapy tended to have a higher vasoactive infusion score (7.1, 7.6, 9.4, and 11.3) than patients in the control group (6.3, 6.1, 6.0, and 6.7). Although this difference became more pronounced over time, it did not reach statistical significance. The use of preoperative ACE inhibitors and ARBs in pediatric patients undergoing cardiac surgery did not significantly increase the incidence of hypotension after induction of anesthesia and did not increase significantly the vasoconstrictor requirements upon weaning from cardiopulmonary bypass; however, additional prospective studies are needed.

UR - http://www.scopus.com/inward/record.url?scp=84925884282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925884282&partnerID=8YFLogxK

U2 - 10.1177/2150135114549748

DO - 10.1177/2150135114549748

M3 - Article

VL - 5

SP - 515

EP - 521

JO - World journal for pediatric & congenital heart surgery

JF - World journal for pediatric & congenital heart surgery

SN - 2150-1351

IS - 4

ER -